Farmer Brothers Coffee Reports Third Quarter Fiscal 2025 Financial Results
| FARMER BROS. CO. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (In thousands, except share and per share data) | ||||||||||||||||
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Net sales | $ | 82,054 | $ | 85,358 | $ | 257,140 | $ | 256,698 | ||||||||
| Cost of goods sold | 47,550 | 51,127 | 146,480 | 155,571 | ||||||||||||
| Gross profit | 34,504 | 34,231 | 110,660 | 101,127 | ||||||||||||
| Selling expenses | 27,103 | 28,001 | 81,090 | 82,970 | ||||||||||||
| General and administrative expenses | 8,551 | 9,581 | 29,337 | 32,066 | ||||||||||||
| Net losses (gains) on disposal of assets | 2,413 | (2,883 | ) | 5,607 | (15,806 | ) | ||||||||||
| Operating expenses | 38,067 | 34,699 | 116,034 | 99,230 | ||||||||||||
| (Loss) income from operations | (3,563 | ) | (468 | ) | (5,374 | ) | 1,897 | |||||||||
| Other (expense) income: | ||||||||||||||||
| Interest expense | (1,930 | ) | (1,849 | ) | (5,643 | ) | (5,978 | ) | ||||||||
| Other, net | 704 | 1,635 | 1,487 | 4,830 | ||||||||||||
| Total other expense | (1,226 | ) | (214 | ) | (4,156 | ) | (1,148 | ) | ||||||||
| (Loss) income before taxes | (4,789 | ) | (682 | ) | (9,530 | ) | 749 | |||||||||
| Income tax expense | 187 | - | 239 | 32 | ||||||||||||
| Net (loss) income | $ | (4,976 | ) | $ | (682 | ) | $ | (9,769 | ) | $ | 717 | |||||
| Net (loss) income available to common stockholders per common share, basic and diluted | $ | (0.23 | ) | $ | (0.03 | ) | $ | (0.46 | ) | $ | 0.03 | |||||
| Weighted average common shares outstanding-basic | 21,446,194 | 21,104,728 | 21,340,682 | 20,743,861 | ||||||||||||
| Weighted average common shares outstanding-diluted | 21,446,194 | 21,104,728 | 21,340,682 | 20,948,329 |
| FARMER BROS. CO. CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share and per share data) | |||||||
| March 31, 2025 | June 30, 2024 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 4,054 | $ | 5,830 | |||
| Restricted cash | 178 | 175 | |||||
| Accounts receivable, net of allowance for credit losses of $650 and $710, respectively | 24,498 | 35,147 | |||||
| Inventories | 51,252 | 57,230 | |||||
| Short-term derivative assets | - | 11 | |||||
| Prepaid expenses | 4,226 | 4,236 | |||||
| Assets held for sale | 352 | 352 | |||||
| Total current assets | 84,560 | 102,981 | |||||
| Property, plant and equipment, net | 28,890 | 34,002 | |||||
| Intangible assets, net | 9,583 | 11,233 | |||||
| Right-of-use operating lease assets | 39,140 | 35,241 | |||||
| Other assets | 986 | 1,756 | |||||
| Total assets | $ | 163,159 | $ | 185,213 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | 36,648 | 48,478 | |||||
| Accrued payroll expenses | 8,444 | 10,782 | |||||
| Right-of-use operating lease liabilities - current | 16,580 | 14,046 | |||||
| Short-term derivative liability | - | 730 | |||||
| Other current liabilities | 3,271 | 2,997 | |||||
| Total current liabilities | 64,943 | 77,033 | |||||
| Long-term borrowings under revolving credit facility | 23,300 | 23,300 | |||||
| Accrued pension liabilities | 10,910 | 12,287 | |||||
| Accrued postretirement benefits | 822 | 789 | |||||
| Accrued workers' compensation liabilities | 2,557 | 2,378 | |||||
| Right-of-use operating lease liabilities - noncurrent | 23,140 | 21,766 | |||||
| Other long-term liabilities | 223 | 2,111 | |||||
| Total liabilities | $ | 125,895 | $ | 139,664 | |||
| Commitments and contingencies | |||||||
| Stockholders' equity: | |||||||
| Common stock, $1.00 par value, 50,000,000 shares authorized; 21,510,110 and 21,264,327 shares issued and outstanding as of March 31, 2025 and June 30, 2024, respectively | 21,510 | 21,265 | |||||
| Additional paid-in capital | 81,272 | 79,963 | |||||
| Accumulated deficit | (40,122 | ) | (30,354 | ) | |||
| Accumulated other comprehensive loss | (25,396 | ) | (25,325 | ) | |||
| Total stockholders' equity | $ | 37,264 | $ | 45,549 | |||
| Total liabilities and stockholders' equity | $ | 163,159 | $ | 185,213 |
| FARMER BROS. CO. | |||||||
| CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) | |||||||
| (In thousands) | |||||||
| Nine Months Ended March 31, | |||||||
| 2025 | 2024 | ||||||
| Cash flows from operating activities: | |||||||
| Net (loss) income | $ | (9,769 | ) | $ | 717 | ||
| Adjustments to reconcile net (loss) income to net cash provided (used in) by operating activities | |||||||
| Depreciation and amortization | 8,655 | 8,675 | |||||
| Net losses (gains) on disposal of assets | 4,807 | (17,019 | ) | ||||
| Net losses on derivative instruments | 3,507 | 363 | |||||
| 401(k) and share-based compensation expense | 1,554 | 3,368 | |||||
| Provision for credit losses | 276 | 551 | |||||
| Change in operating assets and liabilities: | |||||||
| Accounts receivable, net | 11,173 | 13,007 | |||||
| Inventories | 5,978 | (5,119 | ) | ||||
| Derivative (liabilities) assets, net | (5,804 | ) | (594 | ) | |||
| Other assets | 806 | 2,035 | |||||
| Accounts payable | (11,756 | ) | (17,203 | ) | |||
| Accrued expenses and other | (3,075 | ) | (1,933 | ) | |||
| Net cash provided by (used in) operating activities | $ | 6,352 | $ | (13,152 | ) | ||
| Cash flows from investing activities: | |||||||
| Sale of business | (800 | ) | (1,214 | ) | |||
| Purchases of property, plant and equipment | (7,352 | ) | (10,267 | ) | |||
| Proceeds from sales of property, plant and equipment | 196 | 24,847 | |||||
| Net cash (used in) provided by investing activities | $ | (7,956 | ) | $ | 13,366 | ||
| Cash flows from financing activities: | |||||||
| Proceeds from Credit Facilities | 8,000 | 6,279 | |||||
| Repayments on Credit Facilities | (8,000 | ) | (6,000 | ) | |||
| Payments of finance lease obligations | (144 | ) | (144 | ) | |||
| Payment of financing costs | (25 | ) | (69 | ) | |||
| Net cash (used in) provided by financing activities | $ | (169 | ) | $ | 66 | ||
| Net (decrease) increase in cash and cash equivalents and restricted cash | (1,773 | ) | 280 | ||||
| Cash and cash equivalents and restricted cash at beginning of period | 6,005 | 5,419 | |||||
| Cash and cash equivalents and restricted cash at end of period | $ | 4,232 | $ | 5,699 |
| Supplemental disclosure of non-cash investing and financing activities: | |||||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | $ | 14,521 | $ | 11,039 | |||
| Non-cash issuance of 401(K) common stock | - | 595 | |||||
| Non cash additions to property, plant and equipment | 75 | 19 |
Non-GAAP Financial Measures
In addition to net (loss) income determined in accordance with U.S. generally accepted accounting principles (“GAAP”), we use the following non-GAAP financial measures in assessing our operating performance:
“EBITDA” is defined as net (loss) income excluding the impact of:
- income tax expense; interest expense; and depreciation and amortization expense.
“EBITDA Margin” is defined as EBITDA expressed as a percentage of net sales.
“Adjusted EBITDA” is defined as net (loss) income excluding the impact of:
- income tax expense; interest expense; depreciation and amortization expense; 401(k) and share-based compensation expense; net losses (gains) on disposal of assets; loss related to sale of business; and severance costs.
“Adjusted EBITDA Margin” is defined as Adjusted EBITDA expressed as a percentage of net sales.
For purposes of calculating EBITDA and EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin, we have excluded the impact of interest expense resulting from non-cash pretax pension and postretirement benefits. For purposes of calculating Adjusted EBITDA and Adjusted EBITDA Margin, beginning with the period ended June 30, 2024 and any period thereafter, we are also excluding the impact of the loss related to sale of business, as this item is not reflective of our ongoing operating results.
We believe these non-GAAP financial measures provide a useful measure of the Company's operating results, a meaningful comparison with historical results and with the results of other companies, and insight into the Company's ongoing operating performance. Further, management utilizes these measures, in addition to GAAP measures, when evaluating and comparing the Company's operating performance against internal financial forecasts and budgets.
We believe that EBITDA facilitates operating performance comparisons from period to period by isolating the effects of certain items that vary from period to period without any correlation to core operating performance or that vary widely among similar companies. These potential differences may be caused by variations in capital structures (affecting interest expense), tax positions (such as the impact on periods or companies of changes in effective tax rates or net operating losses) and the age and book depreciation of facilities and equipment (affecting relative depreciation expense). We also present EBITDA and EBITDA Margin because (i) we believe that these measures are frequently used by securities analysts, investors and other interested parties to evaluate companies in our industry, (ii) we believe that investors will find these measures useful in assessing our ability to service or incur indebtedness, and (iii) we use these measures internally as benchmarks to compare our performance to that of our competitors.
EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin, as defined by us, may not be comparable to similarly titled measures reported by other companies. We do not intend for non-GAAP financial measures to be considered in isolation or as a substitute for other measures prepared in accordance with GAAP.
Set forth below is a reconciliation of reported net (loss) income to EBITDA (unaudited):
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net (loss) income | $ | (4,976) | $ | (682) | $ | (9,769) | $ | 717 | ||||||||
| Income tax expense | 187 | - | 239 | 32 | ||||||||||||
| Interest expense (1) | 655 | 635 | 1,913 | 2,334 | ||||||||||||
| Depreciation and amortization expense | 2,838 | 2,883 | 8,655 | 8,675 | ||||||||||||
| EBITDA | $ | (1,296) | $ | 2,836 | $ | 1,038 | $ | 11,758 | ||||||||
| EBITDA Margin | (1.6) | % | 3.3 | % | 0.4 | % | 4.6 | % | ||||||||
| Net (loss) income Margin | (6.1) | % | (0.8) | % | (3.8) | % | 0.3 | % |
(1) Excludes interest expense related to pension plans and postretirement benefit plans.
Set forth below is a reconciliation of reported net (loss) income to Adjusted EBITDA (unaudited):
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net (loss) income | $ | (4,976) | $ | (682) | $ | (9,769) | $ | 717 | ||||||||
| Income tax expense | 187 | - | 239 | 32 | ||||||||||||
| Interest expense (1) | 655 | 635 | 1,913 | 2,334 | ||||||||||||
| Depreciation and amortization expense | 2,838 | 2,883 | 8,655 | 8,675 | ||||||||||||
| 401(k) and share-based compensation expense | 518 | 422 | 1,554 | 3,324 | ||||||||||||
| Net losses (gains) on disposal of assets | 1,613 | (2,883) | 4,807 | (17,020) | ||||||||||||
| Loss related to sale of business (2) | 800 | - | 800 | 1,214 | ||||||||||||
| Severance costs | 101 | (104) | 854 | 2,856 | ||||||||||||
| Adjusted EBITDA | $ | 1,736 | $ | 271 | $ | 9,053 | $ | 2,132 | ||||||||
| Adjusted EBITDA Margin | 2.1 | % | 0.3 | % | 3.5 | % | 0.8 | % | ||||||||
| Net (loss) income Margin | (6.1) | % | (0.8) | % | (3.8) | % | 0.3 | % |
(1) Excludes interest expense related to pension plans and postretirement benefit plans.
(2) Result related to the divestiture of Direct Ship business which includes the impact of working capital and other adjustments.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment